- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapeutic approaches for cancer therapy: An updated review
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2015-03-24
DOI
10.3109/21691401.2015.1019669
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adoptive T-Cell Therapy for Cancer: Boutique Therapy or Treatment Modality?
- (2013) C. Yee CLINICAL CANCER RESEARCH
- Therapeutic Dendritic Cell-Based Cancer Vaccines: The State of the Art
- (2013) Marius M. Strioga et al. CRITICAL REVIEWS IN IMMUNOLOGY
- The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
- (2013) Amy E Moran et al. CURRENT OPINION IN IMMUNOLOGY
- Checkpoint blocking antibodies in cancer immunotherapy
- (2013) Chrisann Kyi et al. FEBS LETTERS
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Vaccination with dendritic cell–tumor fusion cells in multiple myeloma patients: a promising strategy?
- (2013) Maria A Garcia-Marquez et al. Immunotherapy
- Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
- (2013) Ethan Q Han et al. Journal of Hematology & Oncology
- CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
- (2013) Marco L. Davila et al. PLoS One
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Cancer vaccines
- (2013) Kavitha Yaddanapudi et al. OncoImmunology
- Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
- (2012) O. J. Finn ANNALS OF ONCOLOGY
- Modulation of GITR for cancer immunotherapy
- (2012) David A Schaer et al. CURRENT OPINION IN IMMUNOLOGY
- Resiquimod, a topical drug for viral skin lesions and skin cancer
- (2012) Thomas Meyer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Immunotherapy of Cancer with 4-1BB
- (2012) D. S. Vinay et al. MOLECULAR CANCER THERAPEUTICS
- Modulating CD27 signaling to treat cancer
- (2012) Carsten Riether et al. OncoImmunology
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
- (2012) Thuy Vu et al. Frontiers in Oncology
- Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors
- (2011) Ahmad Tarhini et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Autologous Versus Allogeneic Cell-Based Vaccines?
- (2011) Giorgio Parmiani et al. CANCER JOURNAL
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Tumour escape mechanisms and their therapeutic implications in combination tumour therapy
- (2010) Sujit K Bhutia et al. CELL BIOLOGY INTERNATIONAL
- Neoplastic stem cells: Current concepts and clinical perspectives
- (2010) Axel Schulenburg et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy
- (2010) Massimo Breccia et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
- (2010) Marc Cartellieri et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice
- (2010) Jean-Emmanuel Sarry et al. JOURNAL OF CLINICAL INVESTIGATION
- Denosumab
- (2010) Steven C. Pageau mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Targeting leukemic stem cells by breaking their dormancy
- (2010) Marieke Alida Gertruda Essers et al. Molecular Oncology
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art
- (2010) Taylor H. Schreiber et al. SEMINARS IN IMMUNOLOGY
- Adjuvant Interferon alfa for melanoma: new evidence-based treatment recommendations?
- (2009) Axel Hauschild Current Oncology
- Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”
- (2009) Gianpietro Dotti et al. HUMAN GENE THERAPY
- Viruses as vaccine vectors for infectious diseases and cancer
- (2009) Simon J. Draper et al. NATURE REVIEWS MICROBIOLOGY
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Epitope Landscape in Breast and Colorectal Cancer
- (2008) N. H. Segal et al. CANCER RESEARCH
- Fully human antibodies from transgenic mouse and phage display platforms
- (2008) Nils Lonberg CURRENT OPINION IN IMMUNOLOGY
- Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab
- (2008) Clive S. Zent et al. LEUKEMIA RESEARCH
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now